↓ Skip to main content

生薬成分ゲラニインに抗インフルエンザウイルス活性を発見

Overview of attention for article published in Farumashia, April 2020
Altmetric Badge

Mentioned by

twitter
2 X users
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
生薬成分ゲラニインに抗インフルエンザウイルス活性を発見
Published in
Farumashia, April 2020
DOI 10.14894/faruawpsj.56.4_346
Authors

吉野 悠希

X Demographics

X Demographics

The data shown below were collected from the profiles of 2 X users who shared this research output. Click here to find out more about how the information was compiled.
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 31 March 2022.
All research outputs
#21,049,824
of 25,852,155 outputs
Outputs from Farumashia
#323
of 460 outputs
Outputs of similar age
#306,490
of 398,451 outputs
Outputs of similar age from Farumashia
#5
of 6 outputs
Altmetric has tracked 25,852,155 research outputs across all sources so far. This one is in the 10th percentile – i.e., 10% of other outputs scored the same or lower than it.
So far Altmetric has tracked 460 research outputs from this source. They receive a mean Attention Score of 3.3. This one is in the 9th percentile – i.e., 9% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 398,451 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 13th percentile – i.e., 13% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 6 others from the same source and published within six weeks on either side of this one.